Position in ATEC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$140,251
-$155,463 QoQ
Shares Held
16,214
-20.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#188
of 265 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ATEC Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026PRELUDE CAPITAL MANAGEMENT, LLC holds $16,970,515 across 13 Medical Devices names. ATEC ranks #11 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
36,381 | $11,487,300 | |
| 2 | AVNS |
Avanos Medical, Inc.
|
115,133 | $2,864,509 | |
| 3 | BIO |
Bio-Rad Laboratories, Inc.
|
2,015 | $591,624 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
19,002 | $286,740 | |
| 5 | DXCM |
Dexcom Inc
|
3,857 | $259,768 | |
| 6 | RXST |
RxSight, Inc.
|
51,600 | $248,712 | |
| 7 | BVS |
Bioventus Inc.
|
25,780 | $243,363 | |
| 8 | VREX |
Varex Imaging Corp
|
23,254 | $242,539 |
All Filings in ATEC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,251 | 16,214 | Shares | Other | 2026-08-14 | |
| 2025-09-30 | $295,714 | 20,338 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $162,859 | 14,672 | Shares | Other | 2025-08-14 | |
| 2024-12-31 | $127,785 | 13,920 | Shares | Other | 2025-02-14 | |
| 2024-06-30 | $383,515 | 36,700 | Shares | Other | 2024-08-14 | |
| 2023-06-30 | $244,366 | 13,591 | Shares | Other | 2023-08-14 | |
| 2022-12-31 | $127,686 | 10,339 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $147,356 | 16,860 | Shares | Other | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||